CATALYST PHARMACEUTICA

Catalyst Pharmaceuticals Announces Publication of Santhera Pharmaceutical’s VISION-DMD Vamorolone (AGAMREE®) Study Results in the Peer-Reviewed Journal Neurology

21 2 2024 08:00:00 提供 Nasdaq GlobeNewswire

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024

14 2 2024 07:03:00 提供 Nasdaq GlobeNewswire

Catalyst Pharmaceuticals, Inc. Announces Closing of Public Offering

09 1 2024 15:05:13 提供 Nasdaq GlobeNewswire

Catalyst Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock

05 1 2024 07:02:06 提供 Nasdaq GlobeNewswire

Catalyst Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock

04 1 2024 15:49:58 提供 Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Announces FIRDAPSE® New Drug Application Submitted in Japan by Partner DyDo Pharma

18 12 2023 05:30:03 提供 Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2024 List of America's Most Successful Small-Cap Companies

05 12 2023 07:03:00 提供 Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Announces Appointment of Michael W. Kalb as Chief Financial Officer and Other Executive Promotions

04 12 2023 07:03:00 提供 Nasdaq GlobeNewswire

Catalyst Pharmaceuticals To Participate in Piper Sandler 35th Annual Healthcare Conference

16 11 2023 07:05:00 提供 Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Reports Strong Third Quarter 2023 Financial Results and Corporate Update

08 11 2023 15:11:02 提供 Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Receives Two New U.S. Patent Allowances For FIRDAPSE®

02 11 2023 09:37:31 提供 Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Partners with Sofie's Journey to Bring Focus on Epilepsy at the 11th Annual Epilepsy Awareness and Education Expo

30 10 2023 07:03:00 提供 Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Reports FDA Approval of AGAMREE® (vamorolone) for Duchenne Muscular Dystrophy Granted to Santhera Pharmaceuticals

26 10 2023 14:19:11 提供 Nasdaq GlobeNewswire

Catalyst Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 8, 2023

23 10 2023 07:03:00 提供 Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer

19 10 2023 07:03:00 提供 Nasdaq GlobeNewswire

Patrick J. McEnany, Chairman and CEO of Catalyst Pharmaceuticals, Receives Prestigious 2023 Lifetime Achievement Award from BioFlorida

16 10 2023 07:03:00 提供 Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Announces FDA Acceptance of the Supplemental New Drug Application for FIRDAPSE®

13 10 2023 07:03:00 提供 Nasdaq GlobeNewswire

Catalyst Pharmaceuticals to Participate at the 2023 Cantor Global Healthcare Conference

18 9 2023 07:03:00 提供 Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Announces Abstract on Lambert Eaton Myasthenic Syndrome (LEMS) to be Presented at the Upcoming IASLC 2023 World Conference of Lung Cancer

16 8 2023 09:56:47 提供 Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Announces Multiple Abstracts on FYCOMPA® (Perampanel) from Eisai Co, Ltd., to be Presented at the 35th International Epilepsy Congress

14 8 2023 07:05:10 提供 Nasdaq GlobeNewswire